Bausch + Lomb Announces Key Leadership Changes
June 01 2023 - 7:00AM
Business Wire
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or
the “Company”), a leading global eye health company dedicated to
helping people see better to live better, announced a reshaping of
its executive leadership team, including the elevation of all
business unit heads. Luc Bonnefoy, senior vice president (SVP),
Surgical; John Ferris, SVP, Consumer; and Yang Yang, SVP, Vision
Care; will join the executive management team of the Company
reporting directly to Brent Saunders, chairman and CEO. Concurrent
with this change, Joseph Gordon, president, Global Consumer,
Surgical and Vision Care, will transition to the role of Strategic
Advisor to Saunders. Additionally, Louis Yu, Ph.D., executive vice
president (EVP) and Chief Quality Officer, has notified Bausch +
Lomb of his intent to retire later this summer, and the Company
will commence an internal and external search for his
replacement.
“I rejoined Bausch + Lomb because I am confident that we can
build upon our 170-year legacy of innovative eye health products
and bring forward the next generation of solutions to meet the
ever-changing eye care needs of patients globally. With these
changes to the executive management team, our leaders will be
closer to customers and patients, which will set the stage for
accelerated growth and propel Bausch + Lomb toward a highly
competitive, efficient and effective future,” said Saunders. “The
next chapter of Bausch + Lomb is built upon the efforts of the
strong business unit leadership we’ve had for the past several
years.”
“I’d also like to express my deep gratitude to Joe Gordon and
Louis Yu. Under Joe’s leadership, the Company has built a broad and
diverse commercial platform across many geographies, and we are
fortunate to have his continued expertise in his new role. I also
want to thank Louis for the vast contributions he has made
throughout his entire career to ensure patients all around the
world receive top-quality health care products and solutions,”
continued Saunders.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift
of sight for millions of people around the world – from the moment
of birth through every phase of life. Its comprehensive portfolio
of more than 400 products includes contact lenses, lens care
products, eye care products, ophthalmic pharmaceuticals,
over-the-counter products and ophthalmic surgical devices and
instruments. Founded in 1853, Bausch + Lomb has a significant
global research and development, manufacturing and commercial
footprint with approximately 13,000 employees and a presence in
nearly 100 countries. Bausch + Lomb is headquartered in Vaughan,
Ontario with corporate offices in Bridgewater, New Jersey. For more
information, visit www.bausch.com and connect with us on Twitter,
LinkedIn, Facebook and Instagram.
Forward-looking Statements This news release may contain
forward-looking statements, which may generally be identified by
the use of the words “anticipates,” “hopes,” “expects,” “intends,”
“plans,” “should,” “could,” “would,” “will,” “may,” “believes,”
“estimates,” “potential,” “target,” or “continue” and variations or
similar expressions. These statements are based upon the current
expectations and beliefs of management and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include, but are not limited to, the
risks and uncertainties discussed in Bausch + Lomb’s filings with
the U.S. Securities and Exchange Commission and the Canadian
Securities Administrators, which factors are incorporated herein by
reference. They also include, but are not limited to, risks and
uncertainties associated with our ability to attract, retain and
motivate our executives and other key employees and the plans and
objectives of the new executive leadership team. Readers are
cautioned not to place undue reliance on any of these
forward-looking statements. These forward-looking statements speak
only as of the date hereof. Bausch + Lomb undertakes no obligation
to update any of these forward-looking statements to reflect events
or circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
© 2023 Bausch + Lomb.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230601005450/en/
Investor Contacts Allison Ryan allison.ryan@bausch.com
(877) 354-3705 (toll free) (908) 927-0735
Media Contacts: Lainie Keller (908) 927-1198
lainie.keller@bausch.com
Bausch plus Lomb (NYSE:BLCO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bausch plus Lomb (NYSE:BLCO)
Historical Stock Chart
From Jul 2023 to Jul 2024